Genentech

The Pharma Deal Of The Year Is…

Make a comment

Off-Label Avastin Use Tied To Eye Injuries

7 Comments

Roche Financing For Genentech Deal Looks Tough

5 Comments

UK’s NICE To Lift Ban On Kidney Cancer Meds

1 Comment

Roche Scraps $450M Plan To Redevelop Swiss HQ

2 Comments

Pharmalot… Pharmalittle… Good Morning

Make a comment

Genentech Disputes Avastin And Blood Clot Risk

1 Comment

Pharmalot… Pharmalittle… Morning Edition

Make a comment

Pharmalot… Pharmalittle… Good Morning

Make a comment

Which Drugmaker Has The Best Oncology PAP?

1 Comment

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/